| Rithvik Balakrishnan, | |
|
450 Clarkson Ave, Brooklyn, NY 11203-2012 | |
| (718) 245-3320 | |
| Not Available |
| Full Name | Rithvik Balakrishnan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Critical Care Medicine |
| Location | 450 Clarkson Ave, Brooklyn, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417342635 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 25MA11800800 (New Jersey) | Primary |
| Entity Name | St Josephs Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205425519 PECOS PAC ID: 8628470325 Enrollment ID: O20210716000520 |
News Archive
MedAptus today announced that it has released a Risk Severity Toolkit to help provider groups measure and manage the disease burden of patients covered under risk-based contracts. The initial version focuses on the Medicare Advantage (MA) patient population where premiums paid to MA health plans are based on enrollees' severity history using the Centers for Medicare and Medicaid Services Hierarchical Condition Categories (HCC) model.
Researchers at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed a miniaturized biochip for investigating the effect of drugs on cancer stem cells (CSCs). Published recently in Nano Today, this new technology could boost the development of more effective cancer drugs.
Mayo Clinic researchers have identified the first immune molecule that appears to play a role in prostate cancer development and in predicting cancer recurrence and progression after surgery.
Scientists at Joslin Diabetes Center have found genetic regions that, when defective, allow the immune system to attack the pancreas - the first in a series of mis-steps that lead to type 1 diabetes. Armed with these findings, published yesterday, March 22, in the journal Immunity, the researchers are now trying to hone in on the exact genes involved, in mice and in human patients.
Medical experts have proposed associations between birth size and rates of adult cancer. To examine this hypothesis, researcher Valerie A. McCormack and colleagues at the London School of Hygiene & Tropical Medicine and the Universities of Uppsala and Stockholm investigated overall and site-specific cancer incidence in relation to birth characteristics in a Swedish population-based cohort.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rithvik Balakrishnan, 450 Clarkson Ave, Brooklyn, NY 11203-2012 Ph: () - | Rithvik Balakrishnan, 450 Clarkson Ave, Brooklyn, NY 11203-2012 Ph: (718) 245-3320 |
News Archive
MedAptus today announced that it has released a Risk Severity Toolkit to help provider groups measure and manage the disease burden of patients covered under risk-based contracts. The initial version focuses on the Medicare Advantage (MA) patient population where premiums paid to MA health plans are based on enrollees' severity history using the Centers for Medicare and Medicaid Services Hierarchical Condition Categories (HCC) model.
Researchers at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed a miniaturized biochip for investigating the effect of drugs on cancer stem cells (CSCs). Published recently in Nano Today, this new technology could boost the development of more effective cancer drugs.
Mayo Clinic researchers have identified the first immune molecule that appears to play a role in prostate cancer development and in predicting cancer recurrence and progression after surgery.
Scientists at Joslin Diabetes Center have found genetic regions that, when defective, allow the immune system to attack the pancreas - the first in a series of mis-steps that lead to type 1 diabetes. Armed with these findings, published yesterday, March 22, in the journal Immunity, the researchers are now trying to hone in on the exact genes involved, in mice and in human patients.
Medical experts have proposed associations between birth size and rates of adult cancer. To examine this hypothesis, researcher Valerie A. McCormack and colleagues at the London School of Hygiene & Tropical Medicine and the Universities of Uppsala and Stockholm investigated overall and site-specific cancer incidence in relation to birth characteristics in a Swedish population-based cohort.
› Verified 2 days ago
Dr. Alexander Usorov, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 447 Atlantic Ave, Brooklyn, NY 11217 Phone: 718-858-6300 | |
Dr. Marcellus Andre Walker, MD Critical Care Medicine Medicare: May Accept Medicare Assignments Practice Location: 2094 Pitkin Ave, Brooklyn, NY 11207 Phone: 718-240-0516 Fax: 718-240-0564 | |
Lotus Ahmed, D.O Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 518 Mcdonald Ave, Brooklyn, NY 11218 Phone: 917-848-5432 Fax: 347-252-6754 | |
Mrs. Sophia Schwartzman, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 Ocean Avenue, Brooklyn, NY 11229 Phone: 518-587-1141 | |
Dr. Haitham M Ahmed, MD, MPH Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Pennsylvania Avenue, Brooklyn, NY 11207 Phone: 718-240-2000 Fax: 718-240-2260 | |
Yanjin Yang, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-3000 | |
Ashwad Afzal, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-5246 |